Validation of a Multi-gene Test for Lung Cancer Risk

Trial Information

Validation of a Multi-gene Test for Lung Cancer Risk

Because more than 160,000 individuals die of lung cancer/year in the United States alone, it
is important to use the best possible methods to determine whether increased surveillance of
individuals at highest risk for lung cancer will result in reduced lung cancer mortality.
The Lung Cancer Risk Test (LCRT) proposed for evaluation promises to accurately identify the
10-15% of the population that is most susceptible to lung cancer based on genetic
predisposition. More than 90 million individuals in the United States alone are
demographically at high risk for lung cancer and potential candidates for increased
surveillance.